(19)
(11) EP 1 196 572 A1

(12)

(43) Date of publication:
17.04.2002 Bulletin 2002/16

(21) Application number: 00948173.0

(22) Date of filing: 27.07.2000
(51) International Patent Classification (IPC)7C12N 15/12, C12N 15/16, C07K 14/72, C07K 14/575, C07K 16/28, G01N 33/566, G01N 33/74, A61K 31/00, A61K 38/22
(86) International application number:
PCT/GB0002/899
(87) International publication number:
WO 0107/606 (01.02.2001 Gazette 2001/05)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

(30) Priority: 27.07.1999 GB 9917627
24.08.1999 GB 9920046

(71) Applicant: SMITHKLINE BEECHAM PLC
Brentford,Middlesex TW8 9EP (GB)

(72) Inventors:
  • DUCKWORTH, David Malcolm,SmithKline Beecham Pharm
    Harlow,Essex CM19 5AW (GB)
  • HILL, Jeffrey,SmithKline Beecham Pharmaceuticals
    Harlow,Essex CM19 5AW (GB)
  • MUIR, Alison Isobel,SmithKline Beecham Pharmac.
    Harlow,Essex CM19 5AW (GB)
  • SZEKERES, Philip Graham,SmithKline Beecham Pharm.
    Harlow,Essex CM19 5AW (GB)

(74) Representative: Connell, Anthony Christopher 
GlaxoSmithKlineCorporate Intellectual Property (CN9.25.19)980 Great West Road
Brentford, Middlesex TW8 9GS
Brentford, Middlesex TW8 9GS (GB)

   


(54) AXOR21, A G-PROTEIN COUPLED RECEPTOR